- Home>
- Specialties>
- Oncology and Hematology>
- Neuroblastoma
Search for Neuroblastoma in Oncology and Hematology
Physician-authored summaries on the latest research on neuroblastoma, editorials on neuroblastoma, and perspectives on neuroblastoma - drawn from the top medical journals.
Sort by:
Items 1 to 8 of 8 results - Relevance
- Date
You searched for: neuroblastoma in Oncology and Hematology
-
Genetic Marker for Clinically Aggressive Neuroblastoma
- June 3, 2008
- Susan L. Cohn, MD
- Oncology and Hematology
DNA variants contribute to likelihood of developing high-risk neuroblastoma.- Reviewing:
- Maris JM et al., N Engl J Med 2008 May 7;: Kushner BH and Cheung N-KV., N Engl J Med 2008 May 7;:
-
Point Mutations Predict Prognosis of Patients with Myelodysplasia
- June 29, 2011
- David Green, MD, PhD
- Oncology and Hematology
Specific mutations were associated with overall survival, thrombocytopenia, and elevated percentage of bone marrow blasts.- Reviewing:
- Bejar R et al., N Engl J Med 2011 Jun 30; 364:2496. Odenike O and Le Beau MM., N Engl J Med 2011 Jun 30; 364:2545.
-
Risk Factors for Breast Cancer Recurrence and Systemic Disease
- June 1, 2010
- William J. Gradishar, MD
- Oncology and Hematology
Locoregional tumor recurrence following breast-conserving surgery and radiotherapy raised risk for distant metastases.- Reviewing:
- Botteri E et al., Ann Oncol 2010 Apr; 21:723.
-
Can Anthracycline Response Be Predicted from HER2 and TOP2A Status of Breast Tumors?
- October 6, 2009
- William J. Gradishar, MD
- Oncology and Hematology
The predictive value of these genetic markers remains unclear.- Reviewing:
- Tubbs R et al., J Clin Oncol 2009 Aug 20; 27:3881. Pritchard KI., J Clin Oncol 2009 Aug 20; 27:3875.
-
Adjuvant Trastuzumab for HER2-Positive Breast Cancer
- February 5, 2007
- William J. Gradishar, MD
- Oncology and Hematology
Like other trials of trastuzumab, HERA showed a reduction in cancer recurrence and mortality with trastuzumab treatment.- Reviewing:
- Smith I et al., Lancet 2007 Jan 6; 369:29-36. Hind D et al., Lancet 2007 Jan 6; 369:3-5.
-
Lapatinib for HER2-Positive Breast Cancer Patients Free
- January 22, 2007
- William J. Gradishar, MD
- Oncology and Hematology
Lapatinib enhances the effects of chemotherapy after disease progression with trastuzumab and does not significantly increase toxicity.- Reviewing:
- Geyer CE et al., N Engl J Med 2006 Dec 28; 355:2733-43.
-
Surviving Childhood Cancer but Succumbing to Long-Term Cardiovascular Disease Free
- March 30, 2010
- Michael G. Douvas, MD
- Oncology and Hematology
Therapies that cure childhood cancers seem to contribute to excess cardiovascular deaths in relatively young survivors of pediatric cancers.- Reviewing:
- Tukenova M et al., J Clin Oncol 2010 Mar 10; 28:1308.
-
Breast Cancer in Childhood Cancer Survivors
- September 15, 2009
- William J. Gradishar, MD
- Oncology and Hematology
Patients who received chest irradiation during treatment for childhood cancers had excess risk for breast cancer.- Reviewing:
- Inskip PD et al., J Clin Oncol 2009 Aug 20; 27:3901.
- Prev
- 1
- Next
Sort by:
Items 1 to 8 of 8 results - Relevance
- Date
